Literature DB >> 8215645

Techniques to enhance extramyocardial collateral blood flow after a cardiomyoplasty.

J D Mannion1, M Magno, P Buckman, W Bailey, V Blood, T Heiman-Patterson, R N Edie, F E Rosato.   

Abstract

OBJECTIVE: Chronic stimulation of a cardiomyoplasty was combined with low-dose infusion of heparin into the arterial supply of the cardiomyoplasty in order to determine if latissimus-derived collateral blood flow could be further enhanced. SUMMARY BACKGROUND DATA: Acute and chronic stimulation of a latissimus dorsi cardiomyoplasty increased extramyocardial collateral blood flow to 35 +/- 9% and 27 +/- 5%, respectively, of normal myocardial blood flow.
METHODS: A model of coronary artery disease was created with an ameroid constrictor in goats, and a cardiomyoplasty was performed. Heparin (15 to 50 U/h) was delivered into the left subclavian artery for a period of 4 weeks. Simultaneously, the latissimus dorsi was chronically stimulated at 2 Hz.
RESULTS: Chronic ischemic myocardium received a collateral flow per gram from the skeletal muscle equivalent to 11.8 +/- 5.2% of the blood flow to normal myocardium. The extramyocardial collateral flow correlated with the latissimus muscle flow (r = 0.72).
CONCLUSIONS: Enhancement of extramyocardial collateral flow was not found with heparin treatment. In view of the correlation of extra-coronary collateral flow with latissimus muscle flow, the lack of a heparin effect may have been due to low latissimus blood flow. These results suggest that extramyocardial collateral blood flow to the myocardium is highest if the blood flow to the latissimus dorsi muscle is maintained.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215645      PMCID: PMC1243015          DOI: 10.1097/00000658-199310000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  Creation of anastomoses between an extracardiac artery and the coronary circulation. Proof that myocardial angiogenesis occurs and can provide nutritional blood flow to the myocardium.

Authors:  E F Unger; C D Sheffield; S E Epstein
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

2.  RESTORATION OF CORONARY CIRCULATION BY ANASTOMOSIS.

Authors:  A M Vineberg
Journal:  Can Med Assoc J       Date:  1946-08       Impact factor: 8.262

3.  Effect of heparin on the angiogenic potency of basic and acidic fibroblast growth factors in the rabbit cornea assay.

Authors:  J M Herbert; M C Laplace; J P Maffrand
Journal:  Int J Tissue React       Date:  1988

4.  Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique.

Authors:  R G Favaloro
Journal:  Ann Thorac Surg       Date:  1968-04       Impact factor: 4.330

5.  After a cardiomyoplasty, collaterals from skeletal muscle form to chronic ischemic myocardium.

Authors:  P D Buckman; J D Mannion; M Magno; F DiMeo; M McHugh
Journal:  Artif Organs       Date:  1992-06       Impact factor: 3.094

6.  Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

Authors:  T Maciag; T Mehlman; R Friesel; A B Schreiber
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

7.  Increased expression of fibroblast growth factors in a rabbit skeletal muscle model of exercise conditioning.

Authors:  N G Morrow; W E Kraus; J W Moore; R S Williams; J L Swain
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

8.  Heparin protects basic and acidic FGF from inactivation.

Authors:  D Gospodarowicz; J Cheng
Journal:  J Cell Physiol       Date:  1986-09       Impact factor: 6.384

9.  Effects of heparin treatment on collateral development and regional myocardial function in acute myocardial infarction.

Authors:  M Ejiri; M Fujita; K Miwa; T Hirai; K Yamanishi; O Sakai; S Ishizaka; S Sasayama
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

10.  Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs.

Authors:  S L Hale; K J Alker; R A Kloner
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.